Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells

Cell Death and Differentiation

Volumn 6, Issue 5, 1999, Pages 471-480

  Friesen, Claudia ^a   Fulda, Simone ^a   Debatin, Klaus Michael ^a,b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; CD95 ligand; Doxorubicin; Glutathione; Mitochondria; Redox state

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; DOXORUBICIN; FAS LIGAND; GLUTATHIONE; PROTEIN BCL X; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NEUROBLASTOMA CELL; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN INDUCTION;

EID: 0033062872     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400512     Document Type: Article

References (69)

1. Barry MA, Behnke CA and Eastman A (1990) Activation of programmed cell death (apootosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40: 2353-2362
2. Hickman JA, Potten CS, Merrit AJ and Fisher TC (1994) Apoptosis and cancer chemotherapy. Philos. Trans. R. Soc. Lon. B. Biol. Sci. 345: 319-325
3. Debatin KM, Goldman CK, Bamford R, Waldmann TA and Krammer PH (1990) Monoclonal antibody-mediated apoptosis in adult T cell leukemia. Lancet 335: 497-500
4. Debatin KM, Goldman CK, Waldmann TA and Krammer PH (1993) APO-1 induced apoptosis of leukemia cells from patients with adult T cell leukemia. Blood 81: 2972-2977
5. Krammer PH, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Fath M, Daniel PT, Knipping E, Westendorp MO, Stricker K, Bäumler C, Hellbardt S, Germer M, Peter ME and Debatin KM (1994) The role of APO-1-mediated apoptosis in the immune system. Immunol. Rev. 142: 175-191
6. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
7. Trauth BC, Klas C, Peter AMJ, Matz S, Möller P, Falk W, Debatin KM and Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305
8. Debatin KM (1996) Disturbances of the CD95 (APO-1/Fas) system in disorders of lymphohaematopoietic cells. Cell Death Differ. 3: 185-189
9. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Sato N and Nagata S (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243
10. Kischkel FC, Hellbardt S, Behrmann I, Gremer M, Pawlita M, Krammer PH and Peter M (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins (CAP) form a death-inducing signalling complex (DISC) with the receptor. EMBO J. 14: 5579-5588
11. Klas C, Debatin KM, Jonker RR and Krammer PH (1993) Activation interferes with the apoptotic pathway in mature human T cells. Internat. Immunol. 5: 625-630
12. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth B, Ponstingl H and Krammer PH (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J. Biol. Chem. 267: 10709-10715
13. Peter ME, Kischkel FC, Hellbrandt S, Chinnaiyan AM, Krammer PH and Dixit VM (1996) CD95 (APO-1/Fas)-associating signaling proteins. Cell Death Differ. 3: 161-170
14. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827
15. Dhein J, Walczak H, Bäumler C, Debatin KM and Krammer PH (1995) Autocrine T cell suicide mediated by APO-1 (Fas/CD95). Nature 373: 438-441
16. Suda T, Takahashi S, Golstein P and Nagata S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178
17. Tanaka M, Suda T, Takahashi T and Nagata, S (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14: 1129-1135
18. Friesen C, Herr, I, Krammer PH and Debatin KM (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Medicine 2: 574-577
19. Friesen C, Fulda S and Debatin KM (1997) Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells. Leukemia 11: 1833-1841
20. Friesen C, Fulda S and Debatin KM (1999) Cytotoxic drugs and the CD95 pathway. Leukemia 13: in press
21. Fulda S, Sieverts H, Friesen C, Herr I and Debatin K-M (1997) The CD95 (APO-1/ Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res. 57: 3823-3829
22. Fulda S, Los M, Friesen C and Debatin K-M (1998) Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system. Int. J. Cancer 76: 105-114
23. Müller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH and Galle PR (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wilde-type p53. J. Clin. Invest. 99: 403-413
24. Houghton JA, Harwood FG and Tillman DM (1997) Thymineless death in colon carcinoma cells is mediated via Fas signaling. Proc. Natl. Acad. Sci. USA 94: 8144-8149
25. Kasibatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A and Green DR (1998) DNA damaging agents induce expression of FAS ligand and subsequent apoptosis in T lymphocytes via activation of NF-κB. Molecular Cell 1: 543-551
26. Strand S, Hofmann WJ, Grambihler A, Hug H, Volkmann M, Otto G, Wesch H, Mariani SM, Hack V, Stremmel W, Krammer PK and Galle PR (1998) Hepatic failure and liver damage in acute Wilson's disease involve CD95 (APO-1/fas) mediated apoptosis. Nature Medicine 4: 588-593
27. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung SJ, Earnshaw WC, Leibson PJ and Kaufmann SH (1997) Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interaction. Blood 90: 935-943
28. Ferrari D, Stepczynska A, Los M, Wesselborg S and Schulze-Osthoff K (1998) Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95-and anticancer drug-induced apoptosis. J. Exp. Med. 188: 979-984
29. Gamen S, Anel A, Lasierra P, Alava MA, Martinez-Lorenzo MJ, Pineiro A and Naval J (1997) Doxorubicin-induced apoptosis in human T cell leukemia is mediated by caspase-3 activation in a Fas-independent way. FEBS Lett. 417: 360-364
30. Kataoka T, Schroter M, Hahne M, Schneider P, Irmler M, Thome M, Froelich CJ and Tschopp J (1998) FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation. J. Immunol. 161: 3936-3942
31. McGahon AJ, Pereira Costa AP, Daly L and Cotter TG (1998) Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of Fas (APO-1/ CD95) receptor/ligand system. Br. J. Haematol 101: 539-547
32. Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G and Rausa L (1998) The CD95/CD 95 ligand systerr is not the major effector in anticancer drug-mediated apoptosis. Cell Death Differ. 5: 735-742
33. Villunger A, Egle A, Kos M, Hartmann B L, Stephan G, Kofler R and Greil R (1997) Drug-induced apoptosis is associated with enhanced fas (Apc-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res. 57: 3333-3334
34. L antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 57: 62-67
35. Kroemer G (1997) Mitochondrial implication in apoptosis towards an endosymbiont hypothesis of apoptosis evolution. Cell Death Differ. 214: 443-456
36. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M and Kroemer G (1996) Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184: 1155-1160
37. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX and Koemer G (1995) Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocytes death in vivo. J. Exp. Med. 181: 1661-1672
38. Zamzami N, Susin SA, Marchetti P, HirschT, Gomez-Monterry I, Castedo Mand Kroemer G (1996) Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183: 1533-1544
39. Doroshow JH (1986) Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents. Biochem. Biophys. Res. Commun. 135: 330-335
40. Sandstrom PA, Mannie MD and ButtkeTM (1994) Inhibition of activation-induced death in T cells hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis. J. Leuk. Biol. 55: 221-226
41. Cervantes A, Pinedo HM, Lankelma J and Schuurhuis GJ (1988) The role of oxygen-derived free radicals in the cytotoxicity of doxorubicin in multi-drug resistant and sensitive human ovarian cancer cells. Cancer Letters 41: 169-177
42. Chiba T, Takahashi S, Sato N, Ishii S and Kikuchi K (1996) Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells. Eur. J. Immunol. 26: 1164-1169
43. Dèas O, Dumont C, Mollereau B, Mètivier D, Pasquier C, Bernard-Pomier G, Hirsch F, Charpentier B and Senik A (1997) Thiol-mediated inhibition of Fas and CD2 apoptotic signaling in activated human peripheral T cells. Int. Immunol. 9: 117-125
44. Hedley D and Chow S (1994) Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 15: 349-358
45. Hedley D and Chow S (1994) Glutathione and Cellular Resistance to anti-Cancer Drugs. Methods Cell Biol. 42: 31-44
46. Sato N, Iwata S, Nakamura K, Hori T, Mori K and Yodoi J (1995) Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than glutathione in T cells apoptosis. J. Immunol. 154: 3194-3203
47. Dusre L, Mimnaugh EG, Myers CE and Sinha BK (1989) Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells. Cancer Res. 49: 511-515
48. Hug H, Strand S, Grambihler A, Galle J, Hack V, Stremmel W, Krammer PH and Galle PR (1997) Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells J. Biol. Chem. 272: 28191-28193
49. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM (1995) Yama/CPP32Β, a mammalian homolog of Ced-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801-809
50. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, Walter P and Yaffee M (1995) Oxidants in mitochondria: from physiological diseases. Biochim. Biophys. Acta 1271: 67-74
51. Chance B, Sies H and Boveris A (1979) Hydrogen peroxide metabolism in mammalian organs. Physiol. Rev. 59: 527-605
52. Abate C, Patel L, Rauscher III FJ and Curran T (1990) Redox regulation of Fos and Jun DNA binding activity in vitro. Science 249: 1157-1161
53. Gracia-Ruiz C, Colell A, Morales A, Kaplowitz N and Fernandez-Checa JC (1995) Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor NF-κB: studies with isolated mitochondria and rat hepatocytes. Mol. Pharmacol. 48: 825-834
54. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA and Fiers W (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage to mitochondrial functions. J. Biol. Chem. 267: 5317-5323
55. Doroshow JH (1983) Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide and hydroxyl radical production by NADH dehydrogenase. Cancer Res. 43: 4543-4551
56. Doroshow JH (1983) Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res. 43: 460-472
57. Doroshow JH and Davies KJ (1986) Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J. Biol. Chem. 261: 3068-3074
58. Sinha BK, Katki AG, Batist G, Cowan KH, and Myers CE (1987) Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells. Biochem. Pharmacol. 36: 793-796
59. Boland MP, Foster SJ and O'Neill LA (1997) Daunorubicin activates NF-κB and induces NF-κB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphomy cells. J. Biol. Chem. 272: 12952-12960
60. Holtz-Heppelmann CJ, Algeciras A, Badley AD, Paya CV (1998) Transcritional regulation of human FasL promotor-enhancer region. J. Biol. Chem. 237: 4416-4423
61. Staal FJT, Ela SW, Roederer M, Anderson MT, Herzenberg LA and Herzenberg, LA (1992) Glutathione deficiency and human imunodeficiency virus infection. Lancet 339: 909-912
62. Malorni W, Rivabene MT, Santini MT and Donelli G (1993) N-acetycysteine inhibits apoptosis and decreases viral particles in HIV chronically infected U937 cells. FEBS Lett. 327: 75-78
63. Castedo M, Macho A, Zamzami N, Hirsch T, Marchetti P, Uriel J and Kroemer G (1995) Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur. J. Immunol. 25: 3277-3284
64. Macho A, Castedo M, Marchetti P, Aguilar JJ, Decaudin D, Zamzami N, Girard PM, Uriel J and Kroemer G (1995) Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. Blood 86: 2481-2487
65. Jacobson MD (1996) Reactive oxygen species and programmed cell death TiBS 21: 83-86
66. Scaffidi CA, FuldaS, Srinivasan A, Friesen C, Feng L, Tomaselli KJ, Debatin KM, Krammer PH and Peter ME (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675-1687
67. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Meth. 139: 271-279
68. Carbonari M, Cibati M, Cherchi M, Sbarigia D, Pesce AM, Dell'Ann L, Modica A and Fiorelli M (1994) Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus-infection and cancer chemotherapy by a novel flow immunocytometric method. Blood 83: 1268-1277
69. Peter ME, Dhein J, Ehret A, Hellbardt S, Walczak H, Moldenhauer G and Krammer PH (1995) APO-1 (CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines. Int. Immunol. 7: 1873-1877